fundmomentum.vc

Brandon Capital Australasia Fund 6

Australia
Growth
Share

About Brandon Capital Australasia Fund 6

Life Sciences, HealthTech, MedTech focused fund

Investment Focus

Location / RegionAustralia
Funding StageGrowth
Industry Focus
Biotech
Digital Health
Med Tech

Investor Signals Profile

active

Sweet Spot

ANZ biotech/medtech with clinical proof, US scaling ready

medtech
oncology
life sciences
Australia/ANZ
radioligand therapies
clinical-stage biotech
US scaling model
inflammasome therapeutics
neurotology
medical devices

Bullish Signals

Portfolio co presenting at RACS 2026external
Active medtech portfolio engagementexternal
OncoRes CMO keynote — RACS Perthlinkedin
Portfolio active in breast cancer trialslinkedin
Brandon Capital amplifying OncoRes RACS sessionslinkedin
Portfolio CMO: dual RACS keynote slotslinkedin
Portfolio CMO: gendered lens surgical carelinkedin
AdvanCell raised US$315m oncology financinglinkedin
Myricx acquired by Novartis post-Brandonlinkedin
Top-tier US/UK/AU syndicate backing portfoliolinkedin
BioCatalyst 6 fund deploying into late-stagelinkedin
6 AU health innovators awarded $13.5m via CUREator+linkedin
CUREator+ milestone-based funding + commercialisation supportlinkedin
MRFF partnership expanding AU research translationlinkedin
Aleris, Frontier Inflammasome, Luma, Navier, Neurotologix, WeGuide fundedlinkedin

Contrarian Signals

Narrow sector focus — healthcare onlyexternal

Founder Do's

Build in medtech or life sciences
Show clinical validation or trials
Target ANZ or Asia-Pacific market
Engage clinical leaders / KOLs
Link to translational research
Plan US expansion post-proof
Syndicate with top-tier US/UK investors
Apply for CUREator+ milestone funding
Leverage Brandon BioCatalyst ecosystem support

Founder Don'ts

Avoid non-healthcare sectors
Don't skip clinical evidence
No consumer or SaaS pitches

Key GPs & Partners

JT
Jonathan Tobin
Partner
oncology focuseddeal makernetworked
CN
Chris Nave
Partner
biotech syndicationUS scalingcapital deployment
MB
Michael Bettess
Partner
capital raisingbiotech ops
PR
Prashanth Rajan
Partner
biotech investor
AV
Amanda Vrselja
Program Head
commercialisationecosystem builder

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View PlansBrowse all Signal Profiles →

Fund Overview

Fund SizeA$439M+
Saves0
Website
LinkedIn

Key People

Dr. Chris Nave, Chris Smith, Melissa McBurnie

Jonathan TobinPartner
Chris NavePartner
Michael BettessPartner
Prashanth RajanPartner
Amanda VrseljaProgram Head

Related Funds

Climate Tech Partners (CTP)

$50M
Australia
Series A
Deep Tech, Climate Sustainability, Ai Ml, Saas
Fund Manager:Atrick Sieb, Tom Kline
Series A
Deep Tech
Climate Sustainability
Ai Ml
Saas

AO Ventures (Tennis Australia's venture capital fund)

$30M
Australia
Seed
Digital Health, Ai Ml
Fund Manager:Todd Deacon, Machar Reid
Seed
Digital Health
Ai Ml

Airtree Ventures

$650M
Australia
Seed
Saas, Ai Ml
Fund Manager:Kelland Reilly, Helen Norton, Jackie Vullinghs
Seed
Saas
Ai Ml